Affiliated Hospital of Yangzhou University Researchers Illuminate Research in Liver Cancer (Discovery of novel and highly potent dual-targeting PKMYT1/HDAC2 inhibitors for hepatocellular carcinoma through structure-based virtual screening and ...)

Prensa/medios de comunicación: !!!Research

Períodonov. 28 2024

Cobertura de los medios

1

Cobertura de los medios

  • NombreAffiliated Hospital of Yangzhou University Researchers Illuminate Research in Liver Cancer (Discovery of novel and highly potent dual-targeting PKMYT1/HDAC2 inhibitors for hepatocellular carcinoma through structure-based virtual screening and ...)
    Nombre/canal del medio de comunicaciónNewsRx Drug Daily
    País/TerritorioEstados Unidos
    Fecha28/11/24
    PersonasYang Yang
Ver todos 1
Ver menos